<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>) are neoplastic disorders of the hematopoietic stem cell </plain></SENT>
<SENT sid="1" pm="."><plain>Four different entities are defined: <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vers, <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythaemia</z:e>, and idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, overlapping entities within the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPDs</z:e> and between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPDs</z:e> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> have been described </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnostic measures are performed to classify the subtype exactly and to assess risk factors and prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>Cytogenetic and molecular analyses are mandatory for the characterization of the malignant clone </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="44423">Hydroxyurea</z:chebi> and interferon-alpha have proven effective in <z:hpo ids='HP_0000001'>all</z:hpo> CMPE </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:mp ids='MP_0005481'>CML</z:mp>, specific inhibition of the elevated ABL tyrosine kinase activity with <z:chebi fb="0" ids="45783">imatinib</z:chebi> is associated with high response rates </plain></SENT>
<SENT sid="7" pm="."><plain>Allogeneic stem cell transplantation is the only curative treatment option for <z:hpo ids='HP_0000001'>all</z:hpo> entities </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:mp ids='MP_0005481'>CML</z:mp>, the decision-making analysis should be based on established scores </plain></SENT>
<SENT sid="9" pm="."><plain>In BCR-ABL negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPDs</z:e> an allogeneic stem cell transplantation should only be performed in patients with unfavorable prognosis </plain></SENT>
</text></document>